Crossmark

N,N-Dimethylglycine in patients with progressive multiple sclerosis: result of a pilot double-blind, placebo, controlled randomized clinical trial

Published Online: 2021-05-24

Published Print: 2021-12

Authors

Wolfsegger, Thomas http://orcid.org/0000-0002-8258-7487
Böck, Klaus

Schimetta, Wolfgang

von Oertzen, Tim J.

Assar, Hamid
License Information

Text and Data Mining valid from 2021-05-24

Version of Record valid from 2021-05-24
More Information

Article History

Received: 18 March 2021

Accepted: 4 May 2021

First Online: 24 May 2021

Declarations

:

: This study was approved by the ethics committee of the government of Upper Austria in line with the Declaration of Helsinki (study number: EK Nr: C-117-16).

: The patients has consented to the publication.

: The authors declare that they have no competing interests.

Document is current